RFA-DA-22-032 - HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Change to Key Dates for RFA-DA-23-032, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)" NOT-DA-22-067 NIDA Aug 23, 2022 Nov 15, 2024 R21

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)


Technical Issues: E-mail OER Webmaster